This article is part of the HBOT Research section, where we summarize published hyperbaric oxygen therapy studies.
What this study looked at
Diabetic foot ulcers are chronic, hard-to-heal wounds that can lead to infection, hospital stays and even amputation. They are one of the most serious complications of diabetes.
This new paper is a huge systematic review and network meta-analysis – the researchers pulled together:
- 67 randomized controlled trials
- 5,957 patients with diabetic foot ulcers
They compared several non-drug treatments that can be added on top of standard wound care, including:
- hyperbaric oxygen therapy
- light therapy
- ultrasound treatment
- extracorporeal shock-wave therapy
- exercise therapy
- continuous oxygen to the wound
- negative pressure wound therapy (vacuum dressings)
- electrical stimulation and a few others
The goal was to see which methods work best for different outcomes like:
- how many wounds heal
- how fast they heal
- how much the wound size shrinks
- how often ulcers come back
- how often amputation is needed
- how many side effects occur
Key findings in simple language
The interesting part of this paper is that it doesn’t look at just one therapy, but ranks many of them side by side.
Light and ultrasound therapy
- Light therapy came out very strong for overall healing rate – more ulcers closed completely.
- Ultrasound therapy was best at shrinking wound size.
Shock-wave and negative pressure
- Shock-wave therapy was best for speeding up healing and also did very well for reducing the risk of amputation.
- Negative pressure (vacuum dressings) was also good for faster healing and wound size reduction.
Exercise and continuous oxygen on the wound
- Exercise therapy was best at preventing ulcers from coming back.
- Continuous oxygen applied directly to the wound had the fewest side effects.
Where does hyperbaric oxygen therapy fit in?
Hyperbaric oxygen was one of the therapies in this big comparison, not the only star of the paper – and that’s actually valuable, because we see how it performs in a realistic mix of options.
Key point:
- In this analysis, patients receiving hyperbaric oxygen in addition to standard care showed a significantly lower risk of amputation compared to standard care alone.
In other words, when added on top of normal wound treatment, it helped more people keep their limb rather than ending up in amputation surgery.
Outcomes like this are often highlighted as especially meaningful in the wound-care field, where preventing limb loss is a major priority.
not just “does the wound look a bit better,” but “does this help avoid amputation?”
Even though some other methods (like shock-wave) ranked slightly higher for amputation in this analysis, hyperbaric oxygen appears in this analysis as one of several evidence-supported adjunct options considered in modern wound care research..
Why this matters for the HBOT world (and especially mild HBOT)
A few important takeaways for us:
- This is not a small pilot, but a big overview of many trials, which gives the results more weight.
- Hyperbaric oxygen is treated here as a serious, mainstream, nurse-led adjunct treatment, not some fringe idea.
- The main benefit highlighted is limb preservation – fewer amputations – which is one of the most meaningful outcomes you can get in diabetic foot care.
While most studies in this analysis used higher-pressure protocols, the biological mechanisms discussed — oxygen delivery, inflammation modulation, vascular signaling — are the same pathways that are often explored in research on mild hyperbaric oxygen exposure, even though protocols and clinical contexts differ.
This fits beautifully with the idea that many effects of mild and higher-pressure HBOT overlap – especially when it comes to wound healing and tissue survival.
Takeaway for the community
This large 2025 analysis sends a clear message:
- There are several effective non-drug tools for diabetic foot ulcers.
- Hyperbaric oxygen therapy is one of them and helps reduce the risk of amputation when added to standard care.
- HBOT belongs firmly in the category of evidence-based adjunct therapies, not “alternative” guesswork.
For readers following HBOT research in the context of diabetic wound care, this large 2025 analysis adds meaningful perspective.
It shows that alongside other non-drug approaches, hyperbaric oxygen has been associated with lower amputation rates in clinical studies — a finding that continues to draw attention in the research community.
When it comes to diabetic foot ulcers, outcomes like healing progression and limb preservation matter deeply — and this paper contributes important data to that conversation.
Link to the study: https://pubmed.ncbi.nlm.nih.gov/41197760
Educational disclaimer
This content summarizes findings from published medical research for educational purposes only.
The hyperbaric chambers sold on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease.
The studies discussed here were conducted in clinical medical settings using medical-grade interventions. The inclusion of research summaries does not imply that similar outcomes can be achieved using non-medical wellness devices.
